Bianca Nitzsche
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Characterization of the New Pentafluorosulfanyl-Substituted Chalcone 246TMP-3SF5 as a Potential New Treatment Option Against Hepatocellular Carcinoma.
Journal: Cancers
Published: June 12, 2026
2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma.
Journal: Cells
Published: February 23, 2026
Rostafuroxin ameliorates cardiac glycoside-induced cardiomyocyte electrolyte imbalances and arrhythmia in ovo.
Journal: American journal of physiology. Heart and circulatory physiology
Published: February 05, 2026
Rostafuroxin ameliorates cardiac glycoside-induced cardiomyocyte electrolyte imbalances and arrhythmia in ovo.
Journal: American journal of physiology. Heart and circulatory physiology
Published: February 05, 2026
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 10, 2024
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 28, 2024
Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents.
Journal: International journal of molecular sciences
Published: January 28, 2023
In-ovo echocardiography for application in cardiovascular research.
Journal: Basic research in cardiology
Published: December 13, 2022
Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes.
Journal: International journal of molecular sciences
Published: November 29, 2022
Editorial: Advances in molecular targeted therapies of urologic cancers.
Journal: Frontiers in oncology
Published: October 05, 2022
New chimeric HDAC inhibitors for the treatment of colorectal cancer.
Journal: Archiv der Pharmazie
Published: August 08, 2022
Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: New chances for sophisticated drug design and treatment optimization.
Journal: Seminars in cell & developmental biology
Published: July 20, 2022
Last Updated: 09/26/2026